belimumab 120 MG Injection
- RxCUI
- 1656395
- RxNorm name
- belimumab 120 MG Injection
- Display name
- belimumab 120 MG Injection
- Full name
- belimumab 120 MG Injection
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:52
Purple Book Biologic Products#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BENLYSTA | BELIMUMAB | GlaxoSmithKline LLC | 2fa3c528-1777-4628-8a55-a69dae2381a3 | 2025-06-20 | Warnings, Adverse reactions | 1656395 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2fa3c528-1777-4628-8a55-a69dae2381a3 | belimumab 120 MG Injection | PSN | 37 | These highlights do not include all the information needed to use BENLYSTA safely and effectively. See full prescribing information for BENLYSTA. BENLYSTA (belimumab) for injection, for intravenous use BENLYSTA (belimumab) injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250620 |
| 2fa3c528-1777-4628-8a55-a69dae2381a3 | belimumab 120 MG Injection | SCD | 37 | These highlights do not include all the information needed to use BENLYSTA safely and effectively. See full prescribing information for BENLYSTA. BENLYSTA (belimumab) for injection, for intravenous use BENLYSTA (belimumab) injection, for subcutaneous use Initial U.S. Approval: 2011 | 20250620 |